Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Cancer Causes & Control
Published in: Cancer Causes & Control 12/2018

01-12-2018 | Original paper

Comprehensive cancer control: promoting survivor health and wellness

Authors: Elizabeth A. Rohan, Nina Miller, Floyd Bonner III, Kristi Fultz-Butts, Mandi L. Pratt-Chapman, Catherine M. Alfano, Kristen Cox Santiago, Kendall Bergman, Eric Tai

Published in: Cancer Causes & Control | Issue 12/2018

Login to get access

Abstract

Purpose

As of 2016, an estimated 15.5 million cancer survivors were living in the United States and the number of cancer survivors is expected to increase to 20.3 million by 2026. Numerous clinical studies have shown that comorbidities, such as obesity and diabetes, and unhealthy lifestyle choices, such as physical inactivity and heavy smoking, negatively influence overall quality of life and long-term survival of cancer survivors. Accordingly, survivorship programs seek to focus on overall wellness, including symptom management, monitoring for late effects of treatment, monitoring for recurrence, helping patients adapt healthy behaviors, and quality of life. This paper provides a broad overview of public health efforts to address the needs of cancer survivors.

Methods

To describe a range of examples of survivorship initiatives in comprehensive cancer control, we analyzed documents from comprehensive cancer control programs and coalitions and solicited detailed examples from several national partners.

Results

Comprehensive cancer control programs, coalitions, and partners are undertaking myriad initiatives to address cancer survivorship and building upon evidence-based interventions to promote healthy behaviors for cancer survivors across the country.

Conclusion

A coordinated public health approach to caring for the growing population of cancer survivors can help address the long-term physical, psychosocial, and economic effects of cancer treatment on cancer survivors and their families.
Literature
1.
2.
3.
4.
5.
American Cancer Society, Cancer Facts & Figs 2018 (2018) American Cancer Society, Atlanta. Accessed 18 Apr 2018
6.
Bluethmann SM, Mariotto AB, Rowland JH (2016) Anticipating the “silver tsunami”: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev 25(7):1029–1036CrossRef
7.
Miller KD et al (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271–289CrossRef
8.
de Moor JS et al (2013) Cancer survivors in the United States: prevalence across the survivorship trajectory and implications for care. Cancer Epidemiol Biomark Prev 22(4):561–570CrossRef
9.
Meyerhardt JA et al (2006) Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Clin Oncol 24(22):3535–3541CrossRef
10.
Denlinger CS, Barsevick AM (2009) The challenges of colorectal cancer survivorship. J Natl Compr Cancer Netw 7(8):883–893CrossRef
11.
Ligibel J (2012) Lifestyle factors in cancer survivorship. J Clin Oncol 30(30):3697–3704CrossRef
12.
Kyrgiou M et al (2017) Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ 356:j477CrossRef
13.
Edwards BK et al (2014) Annual report to the nation on the status of cancer, 1975–2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 120(9):1290–1314CrossRef
14.
De Bruijn KM et al (2013) Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer. Br J Surg 100(11):1421–1429CrossRef
15.
Underwood JM et al (2012) Surveillance of demographic characteristics and health behaviors among adult cancer survivors—Behavioral Risk Factor Surveillance System, United States, 2009. MMWR Surveill Summ 61(1):1–23PubMed
16.
Rohan EA et al (2015) Health behaviors and quality of life among colorectal cancer survivors. J Natl Compr Cancer Netw 13(3):297–302CrossRef
17.
Hewitt M, Greenfield S, Stovall E (2006) From cancer patient to cancer survivor: lost in transition. National Academies Press, Washington, DC
18.
American Society of Clinical Oncology (2017) The State of Cancer Care in America, 2017: a report by the American Society of Clinical Oncology. J Oncol Pract 13(4):e353–e394CrossRef
19.
20.
21.
Rochester PW et al (2010) Comprehensive cancer control: progress and accomplishments. Cancer Causes Control 21(12):1967–1977CrossRef
22.
Hohman K et al (2010) The CCC National Partnership: an example of organizations collaborating on comprehensive cancer control. Cancer Causes Control 21(12):1979–1985CrossRef
23.
Kegler MC, Swan DW (2011) An initial attempt at operationalizing and testing the Community Coalition Action Theory. Health Educ Behav 38(3):261–270CrossRef
24.
Given LS et al (2010) From planning to implementation to outcomes: comprehensive cancer control implementation building blocks. Cancer Causes Control 21(12):1987–1994CrossRef
25.
Lafranca JA et al (2013) Systematic review and meta-analysis of the relation between body mass index and short-term donor outcome of laparoscopic donor nephrectomy. Kidney Int 83(5):931–939CrossRef
26.
Underwood JM et al (2015) An evaluation of cancer survivorship activities across National Comprehensive Cancer Control Programs. J Cancer Surviv 9:554–559CrossRef
27.
Institute of Medicine (2012) The role of obesity in cancer in cancer survival and recurrence. In: Workshop summary. The National Academies Press, Washington, DC
28.
29.
Robison LL et al (2009) The Childhood Cancer Survivor Study: a National Cancer Institute-supported resource for outcome and intervention research. J Clin Oncol 27(14):2308–2318CrossRef
30.
Steele CB et al (2017) Vital signs: trends in incidence of cancers associated with overweight and obesity–United States, 2005–2014. Morb Mortal Wkly Rep 66(39):1052–1058CrossRef
31.
Rice MS et al (2016) Breast cancer research in the nurses’ health studies: exposures across the life course. Am J Public Health 106(9):1592–1598CrossRef
32.
Yuan C et al (2017) Cigarette smoking and pancreatic cancer survival. J Clin Oncol 35(16):1822–1828CrossRef
33.
Stewart SL et al (2013) Gynecologic cancer prevention and control in the National Comprehensive Cancer Control Program: progress, current activities, and future directions. J Womens Health 22(8):651–657CrossRef
34.
U.S. Department of Health and Human Services (2014) The health consequences of smoking: 50 years of progress: a report of the surgeon general. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, Atlanta
35.
Westmaas JL et al (2014) Prevalence and correlates of smoking and cessation-related behavior among survivors of ten cancers: findings from a nationwide survey nine years after diagnosis. Cancer Epidemiol Biomark Prev 23(9):1783–1792CrossRef
36.
Dobson Amato KA et al (2015) Tobacco cessation may improve lung cancer patient survival. J Thorac Oncol 10(7):1014–1019CrossRef
37.
Roach MC et al (2016) It’s never too late: smoking cessation after stereotactic body radiation therapy for non-small cell lung carcinoma improves overall survival. Pract Radiat Oncol 6(1):12–18CrossRef
38.
39.
Lauby-Secretan B et al (2016) Body fatness and cancer–viewpoint of the IARC Working Group. N Engl J Med 375(8):794–798CrossRef
40.
Puckett M et al (2016) Nutrition and physical activity strategies for cancer prevention in Current National Comprehensive Cancer Control Program plans. J Community Health 41(5):1013–1020CrossRef
41.
Damaskos P, Parry C (2015) Cancer survivorship: concepts, interventions, and research. In: Christ G, Messner C, Behar L (eds) Handbook of oncology social work: psychosocial care of people with cancer. Oxford University Press, New York, pp 57–64
42.
Carter J et al (2018) Interventions to address sexual problems in people with cancer: american society of clinical oncology clinical practice guideline adaptation of cancer care ontario guideline. J Clin Oncol 36(5):492–511CrossRef
43.
44.
Shalom MM et al (2011) Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract 7(5):314–318CrossRef
45.
46.
47.
48.
49.
Irwin ML et al (2017) Effect of the LIVESTRONG at the YMCA exercise program on physical activity, fitness, quality of life, and fatigue in cancer survivors. Cancer 123(7):1249–1258CrossRef
50.
Rock CL et al (2012) Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin 62(4):243–274CrossRef
51.
Cancer Support Community (2017) Insight into the patient experience: Cancer Experience Registry report 2017
52.
Rohan EA (2012) Removing the stress from selecting instruments: arming social workers to take leadership in routine distress screening implementation. J Psychosoc Oncol 30(6):667–678CrossRef
53.
National Academies of Sciences, Engineering, and Medicine (2018) Long-term survivorship care after cancer treatment: proceedings of a workshop. The National Academies Press, Washington, DC
54.
Brothers BM et al (2011) Cancer patients with major depressive disorder: testing a biobehavioral/cognitive behavior intervention. J Consult Clin Psychol 79(2):253–260CrossRef
55.
Recklitis CJ, Syrjala KL (2017) Provision of integrated psychosocial services for cancer survivors post-treatment. Lancet Oncol 18(1):e39–e50CrossRef
56.
Andersen BL et al (2014) Screening, assessment, and care of anxiety and depressive symptoms in adults with cancer: an American Society of Clinical Oncology guideline adaptation. J Clin Oncol 32(15):1605–1619CrossRef
57.
Pollack LA et al (2005) Cancer survivorship: a new challenge in comprehensive cancer control. Cancer Causes Control 16(Suppl 1):51–59CrossRef
58.
Koh HK (2010) A 2020 vision for healthy people. N Engl J Med 362(18):1653–1656CrossRef
59.
60.
Koh HK, Blakey CR, Roper AY (2014) Healthy people 2020: a report card on the health of the nation. JAMA 311(24):2475–2476CrossRef
61.
Weir HK et al (2015) Meeting the healthy people 2020 objectives to reduce cancer mortality. Prev Chronic Dis 12:E104CrossRef
62.
Schabath MB et al (2017) Ask and tell: the importance of the collection of sexual orientation and gender identity data to improve the quality of cancer care for sexual and gender minorities. J Oncol Pract 13(8):542–546CrossRef
63.
Ramsey S et al (2013) Washington state cancer patients found to be at greater risk for bankruptcy than people without a cancer diagnosis. Health Aff 32(6):1143–1152CrossRef
64.
Guy GP Jr et al (2013) Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 31(30):3749–3757CrossRef
Metadata
Title
Comprehensive cancer control: promoting survivor health and wellness
Authors
Elizabeth A. Rohan
Nina Miller
Floyd Bonner III
Kristi Fultz-Butts
Mandi L. Pratt-Chapman
Catherine M. Alfano
Kristen Cox Santiago
Kendall Bergman
Eric Tai
Publication date
01-12-2018
Publisher
Springer International Publishing
Published in
Cancer Causes & Control / Issue 12/2018
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-018-1107-z

Other articles of this Issue 12/2018

Cancer Causes & Control 12/2018 Go to the issue

Original paper

Advancing health equity through the National Comprehensive Cancer Control Program

Original paper

A qualitative study of Realtor knowledge, attitudes, and practices related to radon health effects: implications for comprehensive cancer control

Original paper

Evaluating centralized technical assistance as an implementation strategy to improve cancer prevention and control

Editorial

Comprehensive cancer control in the US: 20 years of progress

Original paper

Lung cancer screening: an emerging cancer control issue presents opportunities for an awareness campaign in rural Michigan

Original paper

Collaborating to conquer cancer: the role of partnerships in comprehensive cancer control
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits